Extravascular hemolytic attack after eculizumab therapy for paroxysmal nocturnal hemoglobinuria

被引：0
|
作者：
Akihiro Tomita
Yukari Shirasugi
Takahiko Ito
Hisashi Tsurumi
Tomoki Naoe
机构：
[1] Nagoya University Graduate School of Medicine,Department of Hematology and Oncology
[2] Tokai University Hospital,Department of Hematology and Oncology
[3] Gifu Social Insurance Hospital,Department of Hematology
[4] Gifu University Graduate School of Medicine,First Department of Internal Medicine
来源：
Annals of Hematology | 2012年 / 91卷
关键词：
Hemolytic Anemia; Paroxysmal Nocturnal Hemoglobinuria; Eculizumab; Hemoglobinuria; Intravascular Hemolysis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1139 / 1141
页数：2
相关论文
共 50 条
  • [31] Management of pregnancy in paroxysmal nocturnal hemoglobinuria on long-term eculizumab
    Vekemans, Marie-Christiane
    Lambert, Catherine
    Ferrant, Augustin
    Saussoy, Pascale
    Havelange, Violaine
    Debieve, Frederic
    Van den Neste, Eric
    Michaux, Lucienne
    BLOOD COAGULATION & FIBRINOLYSIS, 2015, 26 (04) : 464 - 466
  • [32] Eculizumab before and after allogeneic hematopoietic stem cell transplantation in a patient with paroxysmal nocturnal hemoglobinuria
    Goker, Hakan
    Uz, Burak
    Buyukasik, Yahya
    Aksu, Salih
    Haznedaroglu, Ibrahim
    Sayinalp, Nilgun
    Karacan, Yasemin
    Tekin, Fatma
    Ozcebe, Osman Ilhami
    TURKISH JOURNAL OF HEMATOLOGY, 2011, 28 (03) : 223 - 227
  • [33] Nationwide study of paroxysmal nocturnal hemoglobinuria in South Korea: paradox of eculizumab
    Ka-Won Kang
    Hyemi Moon
    Byung-Hyun Lee
    Min Ji Jeon
    Eun Sang Yu
    Dae Sik Kim
    Se Ryeon Lee
    Hwa Jung Sung
    Chul Won Choi
    Byung Soo Kim
    Juneyoung Lee
    Yong Park
    Annals of Hematology, 2020, 99 : 1493 - 1503
  • [34] FDA Report: Eculizumab (Soliris®) for the Treatment of Patients with Paroxysmal Nocturnal Hemoglobinuria
    Dmytrijuk, Andrew
    Robie-Suh, Kathy
    Cohen, Martin H.
    Rieves, Dwaine
    Weiss, Karen
    Pazdur, Richard
    ONCOLOGIST, 2008, 13 (09) : 993 - 1000
  • [35] Nationwide study of paroxysmal nocturnal hemoglobinuria in South Korea: paradox of eculizumab
    Kang, Ka-Won
    Moon, Hyemi
    Lee, Byung-Hyun
    Jeon, Min Ji
    Yu, Eun Sang
    Kim, Dae Sik
    Lee, Se Ryeon
    Sung, Hwa Jung
    Choi, Chul Won
    Kim, Byung Soo
    Lee, Juneyoung
    Park, Yong
    ANNALS OF HEMATOLOGY, 2020, 99 (07) : 1493 - 1503
  • [36] Successful Use of Eculizumab in a Pediatric Patient Treated for Paroxysmal Nocturnal Hemoglobinuria
    Bauters, Tiene
    Bordon, Victoria
    Robays, Hugo
    Benoit, Yves
    Dhooge, Catharina
    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2012, 34 (08) : E346 - E348
  • [37] Hemolytic paroxysmal nocturnal hemoglobinuria: 20 years of medical progress
    de Latour, Regis Peffault
    Hosokawa, Kohei
    Risitano, Antonio Maria
    SEMINARS IN HEMATOLOGY, 2022, 59 (01) : 38 - 46
  • [38] Hematopoietic Cell Transplantation for Paroxysmal Nocturnal Hemoglobinuria in the Age of Eculizumab
    Cooper, Jason P.
    Farah, Rafic J.
    Stevenson, Philip A.
    Gooley, Ted A.
    Storb, Rainer
    Scott, Bart L.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2019, 25 (07) : 1331 - 1339
  • [39] Managing a pregnant patient with paroxysmal nocturnal hemoglobinuria in the era of eculizumab
    Danilov, Alexey V.
    Brodsky, Robert A.
    Craigo, Sabrina
    Smith, Hedy
    Miller, Kenneth B.
    LEUKEMIA RESEARCH, 2010, 34 (05) : 566 - 571
  • [40] Advances in the diagnosis and therapy of paroxysmal nocturnal hemoglobinuria
    Brodsky, Robert A.
    BLOOD REVIEWS, 2008, 22 (02) : 65 - 74
12345